Organigram reported $80.1M Q4 2025 net revenue and $259.2M for fiscal 2025, driven by recreational and international cannabis sales despite ongoing net losses.
Trending
- Nebraska Supreme Court Rejects Bid to Overturn Medical Cannabis Laws
- Major Labor Union Urges Massachusetts Voters To Reject Ballot Measure To Roll Back Marijuana Legalization
- Vermont Lt. Gov. Settles with Regulators for Cultivating Cannabis Plants at Unlicensed Location
- DEA pressures medical cannabis business over workers with convictions (Newsletter: September 14, 2026)
- Medical Marijuana Helps Cancer Patients With Pain, Anxiety And Nausea, Government Study Shows
- Trump-Linked PAC Uses Marijuana Business Donations To Campaign For GOP Lawmakers Who Voted Against Legalization
- Pennsylvania Medical Cannabis Program Audit Calls for Increased Oversight
- San Francisco Officials Propose Rules For Cannabis Cafes Where People Could Consume While Listening To Live Music And Ordering Food
